Caspofungin Viatris 50 mg

Caspofungin Viatris 50 mg is a medicine authorised by Swissmedic under authorisation number 67186. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 19 July 2019 and the authorisation is valid without a time limit. ATC code J02AX04 places the medicine in the group Antimycotics for systemic use.

  • Dispensing category A
  • Authorisation number 67186
  • ATC J02AX04
  • Synthetic medicines
Authorisation data
Authorisation number67186
NameCaspofungin Viatris 50 mg
Full nameCaspofungin Viatris 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderViatris Pharma GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ02AX04
First authorisation19 July 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Caspofungin Viatris 50 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA19 July 2019
2Caspofungin Viatris 70 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA19 July 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
31Durchstechflasche(n)J02AX0408.06.0.A
41Durchstechflasche(n)J02AX0408.06.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Caspofungin Viatris 50 mg authorised in Switzerland?

Yes. Caspofungin Viatris 50 mg is authorised by Swissmedic under authorisation number 67186, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Caspofungin Viatris 50 mg have?

Caspofungin Viatris 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Caspofungin Viatris 50 mg?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com